140 related articles for article (PubMed ID: 1522944)
1. Alteration in the pattern of nerve terminal protein immunoreactivity in the perforant pathway in Alzheimer's disease and in rats after entorhinal lesions.
Cabalka LM; Hyman BT; Goodlett CR; Ritchie TC; Van Hoesen GW
Neurobiol Aging; 1992; 13(2):283-91. PubMed ID: 1522944
[TBL] [Abstract][Full Text] [Related]
2. Synaptic and neuritic alterations during the progression of Alzheimer's disease.
Masliah E; Mallory M; Hansen L; DeTeresa R; Alford M; Terry R
Neurosci Lett; 1994 Jun; 174(1):67-72. PubMed ID: 7970158
[TBL] [Abstract][Full Text] [Related]
3. Perforant pathway changes and the memory impairment of Alzheimer's disease.
Hyman BT; Van Hoesen GW; Kromer LJ; Damasio AR
Ann Neurol; 1986 Oct; 20(4):472-81. PubMed ID: 3789663
[TBL] [Abstract][Full Text] [Related]
4. Distribution and developmental expression of the nerve terminal protein NT75 in the rat cerebellum.
Wright DJ; Ritchie TC; Coulter JD
J Comp Neurol; 1991 Feb; 304(4):530-43. PubMed ID: 1901576
[TBL] [Abstract][Full Text] [Related]
5. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease.
Wakabayashi K; Honer WG; Masliah E
Brain Res; 1994 Dec; 667(1):24-32. PubMed ID: 7895080
[TBL] [Abstract][Full Text] [Related]
6. Entorhinal neurofibrillary tangles in Alzheimer disease with Lewy bodies.
Hansen LA; Masliah E; Quijada-Fawcett S; Rexin D
Neurosci Lett; 1991 Aug; 129(2):269-72. PubMed ID: 1745407
[TBL] [Abstract][Full Text] [Related]
7. Reinnervation of the hippocampal perforant pathway zone in Alzheimer's disease.
Hyman BT; Kromer LJ; Van Hoesen GW
Ann Neurol; 1987 Mar; 21(3):259-67. PubMed ID: 3606033
[TBL] [Abstract][Full Text] [Related]
8. A direct demonstration of the perforant pathway terminal zone in Alzheimer's disease using the monoclonal antibody Alz-50.
Hyman BT; Kromer LJ; Van Hoesen GW
Brain Res; 1988 May; 450(1-2):392-7. PubMed ID: 3401721
[TBL] [Abstract][Full Text] [Related]
9. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease.
Snow AD; Nochlin D; Sekiguichi R; Carlson SS
Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929
[TBL] [Abstract][Full Text] [Related]
10. Selective deposition of amyloid-beta protein in the entorhinal-dentate projection of a transgenic mouse model of Alzheimer's disease.
Su Y; Ni B
J Neurosci Res; 1998 Jul; 53(2):177-86. PubMed ID: 9671974
[TBL] [Abstract][Full Text] [Related]
11. Functional alterations in Alzheimer's disease: decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone.
Harr SD; Simonian NA; Hyman BT
J Neuropathol Exp Neurol; 1995 Jan; 54(1):38-41. PubMed ID: 7815078
[TBL] [Abstract][Full Text] [Related]
12. Patterns of aberrant sprouting in Alzheimer's disease.
Masliah E; Mallory M; Hansen L; Alford M; Albright T; DeTeresa R; Terry R; Baudier J; Saitoh T
Neuron; 1991 May; 6(5):729-39. PubMed ID: 1827266
[TBL] [Abstract][Full Text] [Related]
13. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
[TBL] [Abstract][Full Text] [Related]
14. The Proteome of the Dentate Terminal Zone of the Perforant Path Indicates Presynaptic Impairment in Alzheimer Disease.
Haytural H; Mermelekas G; Emre C; Nigam SM; Carroll SL; Winblad B; Bogdanovic N; Barthet G; Granholm AC; Orre LM; Tjernberg LO; Frykman S
Mol Cell Proteomics; 2020 Jan; 19(1):128-141. PubMed ID: 31699905
[TBL] [Abstract][Full Text] [Related]
15. Synaptic pathology of Alzheimer's disease.
Lassmann H; Fischer P; Jellinger K
Ann N Y Acad Sci; 1993 Sep; 695():59-64. PubMed ID: 8239314
[TBL] [Abstract][Full Text] [Related]
16. Senile dementia of the Alzheimer type: is there a correlation between entorhinal cortex and dentate gyrus lesions?
Senut MC; Roudier M; Davous P; Fallet-Bianco C; Lamour Y
Acta Neuropathol; 1991; 82(4):306-15. PubMed ID: 1759562
[TBL] [Abstract][Full Text] [Related]
17. Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus.
Masliah E; Honer WG; Mallory M; Voigt M; Kushner P; Hansen L; Terry R
Acta Neuropathol; 1994; 87(2):135-42. PubMed ID: 8171963
[TBL] [Abstract][Full Text] [Related]
18. Synaptic loss reflected by secretoneurin-like immunoreactivity in the human hippocampus in Alzheimer's disease.
Kaufmann WA; Barnas U; Humpel C; Nowakowski K; DeCol C; Gurka P; Ransmayr G; Hinterhuber H; Winkler H; Marksteiner J
Eur J Neurosci; 1998 Mar; 10(3):1084-94. PubMed ID: 9753176
[TBL] [Abstract][Full Text] [Related]
19. Synaptophysin immunoreactivity in Pick's disease: comparison with Alzheimer's disease and dementia with Lewy bodies.
Lippa CF
Am J Alzheimers Dis Other Demen; 2004; 19(6):341-4. PubMed ID: 15633942
[TBL] [Abstract][Full Text] [Related]
20. [Morphological changes in the human cerebral cortex in dementia].
Braak H; Braak E
J Hirnforsch; 1991; 32(3):277-82. PubMed ID: 1779131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
